PGIM INDIA HEALTHCARE FUND
PGIM Mutual Fund
Sectoral / Thematic Highly Differentiated As of 2026-05-31
Holdings
32
Concentrated
Top 10 weight
63%
Concentration
Active share
90%
Highly Differentiated
Equity
-
Asset allocation
Portfolio
8Sectors
18High-conviction bets
65%Top sector wt.
-Cash
Market-cap allocation
Large cap33%
Mid cap18%
Small cap46%
Asset allocation
Asset mix not available.
Top holdings
11.3%
Divi's Laboratories Ltd.EQUITY
10.0%6.5%
Aster DM Healthcare Ltd.EQUITY
6.4%Rubicon Research Ltd.EQUITY
6.0%Mankind Pharma Ltd.EQUITY
5.2%5.0%
Ajanta Pharma Ltd.EQUITY
4.7%4.2%
Dr. Lal Path Labs Ltd.EQUITY
3.3%3.2%
3.1%
Abbott India Ltd.EQUITY
2.9%2.7%
2.7%
Sai Life Sciences LtdEQUITY
2.6%Anthem Biosciences Ltd.EQUITY
2.2%2.1%
Global Health Ltd.EQUITY
1.8%Cipla Ltd.EQUITY
1.6%Fortis Healthcare Ltd.EQUITY
1.5%PB Fintech Ltd.EQUITY
1.4%Lupin Ltd.EQUITY
1.4%Pfizer Ltd.EQUITY
1.3%Clearing Corporation of India Ltd.CASH_EQUIVALENT
1.2%1.2%
1.1%
Orchid Pharma Ltd.EQUITY
0.9%Lenskart Solutions Ltd.EQUITY
0.7%Clearing Corporation of India Ltd.CASH_EQUIVALENT
0.7%Sagility Ltd.EQUITY
0.5%0.5%
Net Receivables / (Payables)CASH_EQUIVALENT
0.2%nanOTHER
0.0%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- High top-10 concentration (63%).
- Small-cap heavy (46%) - higher volatility.
- Concentrated in Pharmaceuticals & Biotechnology - watch sector risk.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
JioBlackRock Sector Rotation Fund290 holdings · 36% AS
Franklin India Multi-Factor Fund93 holdings · 84% AS
Bandhan Business Cycle Fund93 holdings · 65% AS
WhiteOak Capital Special Opportunities Fund90 holdings · 73% AS
UTI Quant Fund89 holdings · 66% AS
Axis India Manufacturing Fund86 holdings · 73% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
65.2%
25.8%
3.1%
2.1%
1.4%
1.2%
0.7%
0.5%